TY - JOUR
T1 - Breaking through the barrier
T2 - Modelling and exploiting the physical microenvironment to enhance drug transport and efficacy
AU - Gładysz, Magdalena Z.
AU - Stevanoska, Maja
AU - Włodarczyk-Biegun, Małgorzata K.
AU - Nagelkerke, Anika
N1 - Funding Information:
MZG is supported by a PhD scholarship from the Molecular Life and Health Program of the University of Groningen. MKWB is supported by NWO Veni Grant (VI.Veni.192.148), NAWA Polish returns grant (PPN/PPO/2019/1/00004/U/0001), and NCN OPUS grant (2020/37/B/ST5/00743)
Publisher Copyright:
© 2022 The Authors
PY - 2022/5
Y1 - 2022/5
N2 - Pharmaceutical compounds are the main pillar in the treatment of various illnesses. To administer these drugs in the therapeutic setting, multiple routes of administration have been defined, including ingestion, inhalation, and injection. After administration, drugs need to find their way to the intended target for high effectiveness, and this penetration is greatly dependent on obstacles the drugs encounter along their path. Key hurdles include the physical barriers that are present within the body and knowledge of those is indispensable for progress in the development of drugs with increased therapeutic efficacy. In this review, we examine several important physical barriers, such as the blood-brain barrier, the gut-mucosal barrier, and the extracellular matrix barrier, and evaluate their influence on drug transport and efficacy. We explore various in vitro model systems that aid in understanding how parameters within the barrier model affect drug transfer and therapeutic effect. We conclude that physical barriers in the body restrict the quantity of drugs that can pass through, mainly as a consequence of the barrier architecture. In addition, the specific physical properties of the tissue can trigger intracellular changes, altering cell behavior in response to drugs. Though the barriers negatively influence drug distribution, physical stimulation of the surrounding environment may also be exploited as a mechanism to control drug release. This drug delivery approach is explored in this review as a potential alternative to the conventional ways of delivering therapeutics.
AB - Pharmaceutical compounds are the main pillar in the treatment of various illnesses. To administer these drugs in the therapeutic setting, multiple routes of administration have been defined, including ingestion, inhalation, and injection. After administration, drugs need to find their way to the intended target for high effectiveness, and this penetration is greatly dependent on obstacles the drugs encounter along their path. Key hurdles include the physical barriers that are present within the body and knowledge of those is indispensable for progress in the development of drugs with increased therapeutic efficacy. In this review, we examine several important physical barriers, such as the blood-brain barrier, the gut-mucosal barrier, and the extracellular matrix barrier, and evaluate their influence on drug transport and efficacy. We explore various in vitro model systems that aid in understanding how parameters within the barrier model affect drug transfer and therapeutic effect. We conclude that physical barriers in the body restrict the quantity of drugs that can pass through, mainly as a consequence of the barrier architecture. In addition, the specific physical properties of the tissue can trigger intracellular changes, altering cell behavior in response to drugs. Though the barriers negatively influence drug distribution, physical stimulation of the surrounding environment may also be exploited as a mechanism to control drug release. This drug delivery approach is explored in this review as a potential alternative to the conventional ways of delivering therapeutics.
KW - Blood-brain barrier
KW - Extracellular matrix
KW - In vitro models
KW - Intestinal barrier
KW - Mechanical properties
UR - http://www.scopus.com/inward/record.url?scp=85126596042&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2022.114183
DO - 10.1016/j.addr.2022.114183
M3 - Review article
C2 - 35278523
AN - SCOPUS:85126596042
SN - 0169-409X
VL - 184
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
M1 - 114183
ER -